Akero Therapeutics Inc (NASDAQ:AKRO)

41.56
BATS BZX Real-Time Price
As of 12:42pm ET
 +0.06 / +0.14%
Today’s Change
7.52
Today|||52-Week Range
48.24
+96.50%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Akero Therapeutics Inc have a median target of 50.00, with a high estimate of 64.00 and a low estimate of 40.00. The median estimate represents a +20.31% increase from the last price of 41.56.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Akero Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.77
Sales
$0.00
Reporting Date
Mar 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.32%
 
 
 
 
 
 
Growthannually -10.79%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.